COVID-19 Outbreak Impact on Cancer Multidisciplinary Team Meetings. A Multicenter French Experience.

IF 1.8 4区医学 Q3 ONCOLOGY

Cancer Investigation Pub Date : 2024-01-01 Epub Date: 2024-02-05 DOI:10.1080/07357907.2024.2311856

Wafa Bouleftour, Amandine Mondiere-Wichurski, Pierre Fournel, Quentin Reboul

引用次数: 0

Abstract

Multidisciplinary team meeting (MDT) became a standard of care in cancer management. The COVID-19 epidemic induced unprecedented pressure on the health system. The impact of this health crisis on MDTs held within a regional French health structures was analyzed. A decrease in the total number of records discussed in hematological, digestive, thoracic, gynecological and genitourinary MDTs was observed following the 1st wave of the COVID-19 pandemic. This decrease was generally maintained during the 2nd and 3rd wave. MDTs activity back in order from the 4th wave. The COVID-19 pandemic has challenged MDTs settings. The implementation of virtual technologies offers an opportunity to improve MDTs organization.

查看原文本刊更多论文

COVID-19 爆发对癌症多学科团队会议的影响。法国多中心经验。

多学科小组会议（MDT）已成为癌症治疗的标准。COVID-19 疫情给医疗系统带来了前所未有的压力。我们分析了这场医疗危机对法国地区医疗机构内举行的多学科小组会议的影响。在 COVID-19 第一波流行后，血液科、消化科、胸科、妇科和泌尿生殖科 MDT 讨论的记录总数有所减少。在第二和第三波大流行期间，这一下降趋势总体保持不变。从第 4 次疫情开始，MDT 的活动恢复正常。COVID-19 大流行对 MDT 的设置提出了挑战。虚拟技术的实施为改善 MDT 的组织提供了机会。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Investigation 医学-肿瘤学

CiteScore

3.80

自引率

4.20%

发文量

审稿时长

8.5 months

期刊介绍： Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.